» Articles » PMID: 7519102

Reference Values and Hematologic Changes from Birth to 5 Years in Patients with Sickle Cell Disease. Cooperative Study of Sickle Cell Disease

Overview
Specialty Pediatrics
Date 1994 Aug 1
PMID 7519102
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine hematologic changes from birth to 5 years of age and establish hematologic reference values for infants and children with sickle cell disease.

Research Design: Prospective natural history study.

Setting: Nineteen pediatric sickle cell centers across the United States.

Patients: Six hundred ninety-four infants with sickle cell disease (sickle cell anemia, sickle cell-hemoglobin C disease, and sickle-beta-thalassemia) who were enrolled in the Cooperative Study of Sickle Cell Disease at younger than 6 months of age. Median follow-up time through 5 years of age was 4.1 years.

Measurements And Results: We present longitudinal analyses of total hemoglobin concentration, percent fetal hemoglobin values, mean corpuscular volumes, total bilirubin concentration, and red blood cell (RBC), "pocked" RBC, white blood cell, platelet, and reticulocyte counts. Anemia was apparent by 10 weeks of life in infants with sickle cell anemia (SS infants). This anemia was associated with a rising reticulocyte count consistent with a hemolytic process. The reticulocyte count of SS infants increased steadily, exceeding 12% at 5 years of age. The fetal hemoglobin concentration of SS infants declined more slowly than that of infants with sickle cell hemoglobin C disease (SC infants). Pocked RBC counts rose sharply after 6 months of age, and by 1 year, 28% of SS infants had abnormal counts, above 3.5%, indicating poor splenic function. At 3 years of age, 78% of SS patients and 32% of SC patients had abnormal pocked RBC counts. The SS patients with concurrent alpha-thalassemia had, after 6 months of age and throughout early childhood, a slightly higher mean total hemoglobin concentration and lower mean pocked RBC and reticulocyte counts than SS patients without alpha-thalassemia. The hematologic profile of SC infants more closely resembled that of normal black infants, but there was mild anemia (10.5 g/dL) and slightly elevated mean values for reticulocytes (3%) and fetal hemoglobin (3%) during early childhood.

Citing Articles

Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa.

Segbefia C, Smart L, Stuber S, Amissah-Arthur K, Dzefi-Tettey K, Ekpale P Br J Haematol. 2024; 205(6):2470-2480.

PMID: 39406687 PMC: 11637726. DOI: 10.1111/bjh.19832.


The many faces of sickle cell disease in children: complications in the appendicular skeleton.

De La Hoz Polo M, Hudson V, Adu J, Chakravorty S, Haque S Pediatr Radiol. 2024; 54(9):1437-1450.

PMID: 38740606 DOI: 10.1007/s00247-024-05913-9.


Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.

Kirkham J, Estepp J, Weiss M, Rashkin S JAMA Netw Open. 2023; 6(10):e2337484.

PMID: 37851445 PMC: 10585422. DOI: 10.1001/jamanetworkopen.2023.37484.


Comparisons of Severe Maternal Morbidity and Other Adverse Pregnancy Outcomes in Pregnant People With Sickle Cell Disease vs Anemia.

Early M, Eke A, Gemmill A, Lanzkron S, Pecker L JAMA Netw Open. 2023; 6(2):e2254545.

PMID: 36729453 PMC: 9896269. DOI: 10.1001/jamanetworkopen.2022.54545.


The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism.

Peretz S, Livshits L, Pretorius E, Makhro A, Bogdanova A, Gassmann M Front Physiol. 2022; 13:796837.

PMID: 36105295 PMC: 9465245. DOI: 10.3389/fphys.2022.796837.